Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Levorotatory alkaloids of belladonna |
Is a |
True |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Belladonna alkaloids adverse reaction (disorder) |
Causative agent (attribute) |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to belladonna alkaloid |
Causative agent (attribute) |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Belladonna alkaloids - chemical (substance) |
Is a |
True |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Belladonna alkaloid 16.2 mg and opium 30 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Opium+belladonna |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Belladonnine |
Is a |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aluminum hydroxide+belladonna mixture |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Belladonna pediatric 0.05mg/5mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Magnesium trisilicate+belladonna 0.15mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing belladonna |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Belladonna alkaloid 15 mg and secbutabarbital sodium 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aluminum hydroxide+belladonna |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing belladonna and secbutabarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing belladonna alkaloids and ergotamine tartrate and phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing belladonna and magnesium trisilicate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing belladonna in rectal dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing belladonna in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Belladonna alkaloid 15 mg and secbutabarbital sodium 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Belladonna alkaloid 15 mg and secbutabarbital sodium 15 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Belladonna (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |